TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.

S. Jouan-Lanhouet 1 M. I. Arshad 1 Claire Piquet-Pellorce 1 Corinne Martin-Chouly 2 Gwenaelle Le Moigne-Muller 2 F. Van Herreweghe 3 N. Takahashi 3 Odile Sergent 2 Dominique Lagadic-Gossmann 2 P. Vandenabeele 3 Michel Samson 1 Marie-Thérèse Dimanche-Boitrel 2, *
* Auteur correspondant
1 Irset - Institut de recherche, santé, environnement et travail
2 SMS - Stress, membrane et signalisation
Irset - Institut de recherche, santé, environnement et travail
3 Department for Molecular Biomedical Research
Abstract : Although TRAIL (tumor necrosis factor (TNF)-related apoptosis inducing ligand) is a well-known apoptosis inducer, we have previously demonstrated that acidic extracellular pH (pHe) switches TRAIL-induced apoptosis to regulated necrosis (or necroptosis) in human HT29 colon and HepG2 liver cancer cells. Here, we investigated the role of RIPK1 (receptor interacting protein kinase 1), RIPK3 and PARP-1 (poly (ADP-ribose) polymerase-1) in TRAIL-induced necroptosis in vitro and in concanavalin A (Con A)-induced murine hepatitis. Pretreatment of HT29 or HepG2 with pharmacological inhibitors of RIPK1 or PARP-1 (Nec-1 or PJ-34, respectively), or transient transfection with siRNAs against RIPK1 or RIPK3, inhibited both TRAIL-induced necroptosis and PARP-1-dependent intracellular ATP depletion demonstrating that RIPK1 and RIPK3 were involved upstream of PARP-1 activation and ATP depletion. In the mouse model of Con A-induced hepatitis, where death of mouse hepatocytes is dependent on TRAIL and NKT (Natural Killer T) cells, PARP-1 activity was positively correlated with liver injury and hepatitis was prevented both by Nec-1 or PJ-34. These data provide new insights into TRAIL-induced necroptosis with PARP-1 being active effector downstream of RIPK1/RIPK3 initiators and suggest that pharmacological inhibitors of RIPKs and PARP-1 could be new treatment options for immune-mediated hepatitis.
keyword : TRAIL necroptosis colon cancer hepatitis concanavalin A RIPK1/RIPK3
Type de document :
Article dans une revue
Cell Death and Differentiation, Nature Publishing Group, 2012, 19 (12), pp.2003-14. 〈10.1038/cdd.2012.90〉
Liste complète des métadonnées
http://www.hal.inserm.fr/inserm-00871432
Contributeur : Morgane Le Corre <>
Soumis le : mercredi 9 octobre 2013 - 15:30:07
Dernière modification le : mercredi 18 juillet 2018 - 20:02:03

Lien texte intégral

openaccess

Identifiants

Collections

IRSET | IRSET-HIAEC | BIOSIT | UR1-UFR-SVE | IRSET-2 | IRSET-3 | UNIV-ANGERS | UNIV-RENNES

Citation

S. Jouan-Lanhouet, M. I. Arshad, Claire Piquet-Pellorce, Corinne Martin-Chouly, Gwenaelle Le Moigne-Muller, et al.. TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.. Cell Death and Differentiation, Nature Publishing Group, 2012, 19 (12), pp.2003-14. 〈10.1038/cdd.2012.90〉. 〈inserm-00871432〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

253

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD